Thomas R. Carper bought ALPS Medical Breakthroughs ETF (SBIO)
Thomas R. Carper (D-DE), a U.S. Senator, has disclosed 9 trades in ALPS Medical Breakthroughs ETF (SBIO) since 2020, 3 purchases and 6 sales, worth an estimated $72K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Thomas R. Carper bought $1,001 - $15,000 of ALPS Medical Breakthroughs ETF (SBIO) on November 20, 2020. Since that trade, SBIO is up +43.08% against the S&P 500 up +125.18%, an outperformance of -82.10%.
Across these filings, Thomas R. Carper has been a net seller of SBIO (a buy-to-sell ratio of 0.50). The most recent disclosed SBIO transaction shown was dated April 17, 2023. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Thomas R. Carper's SBIO trades vs the price
SBIO is up +43.08% since Thomas R. Carper bought on November 20, 2020, versus +125.18% for the S&P 500.
Performance since this trade
All Thomas R. Carper SBIO trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Thomas R. Carper & SBIO trading FAQ
Is it legal for Thomas R. Carper to trade ALPS Medical Breakthroughs ETF (SBIO) stock?
Yes. Members of Congress are allowed to trade individual stocks, including ALPS Medical Breakthroughs ETF (SBIO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Thomas R. Carper buy SBIO?
Thomas R. Carper disclosed a purchase of $1,001 - $15,000 of ALPS Medical Breakthroughs ETF (SBIO) on November 20, 2020, according to public STOCK Act filings.
How has SBIO performed since Thomas R. Carper's trade?
Since Thomas R. Carper bought SBIO on November 20, 2020, the stock is up +43.08%, versus +125.18% for the S&P 500 over the same period, an outperformance of -82.10%.
How many times has Thomas R. Carper traded SBIO?
Thomas R. Carper has disclosed 9 SBIO trades since 2020 (3 purchases and 6 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SBIO trades?
Quantellect tracks every disclosed congressional trade in ALPS Medical Breakthroughs ETF (SBIO) on the ALPS Medical Breakthroughs ETF congressional trading page, which aggregates filings across all members of Congress.
Thomas R. Carper's SBIO tradesAll congressional filings for ALPS Medical Breakthroughs ETFThomas R. Carper's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.